Furin is identified as the key enzyme responsible for cleaving the apelin precursor. Inhibiting this cleavage could serve as ...
However, the nation has now been embroiled in this "war" for over 50 years, and we are nowhere closer to victory, argues ...
Here, we present you with the most up-to-date scientific facts on some frequent cancer myths and misconceptions.
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...
In localized non-small cell lung cancer (NSCLC), a tumor's ability to use carbon from glucose to feed the tricarboxylic acid ...
While back pain is not typically a symptom of breast cancer, if breast cancer metastasizes (spreads), it can cause back pain. A common site of breast cancer metastasis is the bones. If this occurs, it ...
Million Private Placement Financing from Existing Investors $2.0 Million Funding Advance from the Cancer Prevention and ...
A new study has found that a common type of cancer treatment, called immune checkpoint inhibitors (ICIs), may not be very effective for patients who receive them while hospitalized. Researchers at ...
Colorectal cancer (CRC) is one of the most common and deadly cancers worldwide, accounting for nearly 10% of all cancer cases ...
Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...
A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.